abstract |
The invention provides Form I of compound 6 - ((6,7-dimethoxyquinazolin-4-yl) oxy) -N, 2-dimethylbenzofuran-3-carboxamide, a pharmaceutical composition containing this compound, methods for its preparation, use of this compound for the treatment of diseases associated with inhibition of KDR, and a method of treating diseases associated with inhibition of KDR. |